PHG
Koninklijke Philips NV ADR
NYSE: PHG · HEALTHCARE · MEDICAL DEVICES
$27.16
+0.46% today
Updated 2026-06-05
Market cap
$25.76B
P/E ratio
23.04
P/S ratio
1.46x
EPS (TTM)
$1.15
Dividend yield
3.82%
52W range
$21 – $32
Volume
1.2M
WallStSmart proprietary scores
57
out of 100
Grade: C+
Hold
Investment rating
5.3
Growth
C+5.5
Quality
C+5.5
Profitability
C+5.3
Valuation
C+5/9
Piotroski F-Score
Moderate
1.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$26,230.00
+96475.85%
12-Month target
$26.73
-1.58%
Intrinsic (DCF)
$20.61
Margin of safety
-55.60%
2 Strong Buy0 Buy3 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $116.89M — positive
Risks
- Altman Z 1.55 — distress zone
- Revenue declining -4.70% QoQ
- 55.60% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $17.83B | $18.17B | $18.02B | $17.83B | $17.64B | $18.3B |
| Net income | $-1.61B | $-466.00M | $-702.00M | $895.00M | $151.00M | — |
| EPS | — | — | — | — | $1.15 | $1.53 |
| Free cash flow | $-979.00M | $1.94B | $1.35B | $893.00M | $116.89M | — |
| Profit margin | -9.02% | -2.56% | -3.90% | 5.02% | 5.50% | — |
Peer comparison
Smart narrative
Koninklijke Philips NV ADR trades at $27.16. representing a P/E of 23.04x trailing earnings. Our Smart Value Score of 57/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.55, it sits in the distress. TTM revenue stands at $17.64B. with profit margins at 5.50%. Our DCF model estimates intrinsic value at $20.61.
Frequently asked questions
What is Koninklijke Philips NV ADR's stock price?
Koninklijke Philips NV ADR (PHG) trades at $27.16, on a P/E of 23.0x and a P/S of 1.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Koninklijke Philips NV ADR overvalued?
Koninklijke Philips NV ADR carries a Smart Value Score of 57/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $20.61 against the $27.16 price, so on cash flow terms the market is paying a premium for Koninklijke Philips NV ADR's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Koninklijke Philips NV ADR (PHG)?
The 12-month analyst consensus target is $26,230.00, about 96475.8% above the current $27.16. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of PHG by 2030?
Our research-backed model puts the 2030 base case at $279.23, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of Koninklijke Philips NV ADR (PHG)?
Our DCF model estimates intrinsic value at $20.61, a -55.6% margin of safety versus today's $27.16. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Koninklijke Philips NV ADR's revenue?
Koninklijke Philips NV ADR's trailing twelve-month revenue is $17.64B, and our model projects it reaching about $22.29B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Koninklijke Philips NV ADR's Altman Z-Score is 1.55, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.46x
ROE8.51%
Beta0.93
50D MA$27.02
200D MA$28.04
Shares out0.97B
Float0.95B
Short ratio—
Avg volume1.2M
Performance
1 week+0.00%
1 month+3.49%
3 months-2.33%
YTD-3.58%
1 year—
3 years—
5 years—